Navigate the Complex Path to Clinical Adoption

Built by commercial leaders who have taken diagnostic platforms from FDA clearance to national adoption.

12 questions · 4 minutes · Instant results · Confidential

OUR FRAMEWORK

The Architecture of Market Entry

A structured approach to turning regulatory milestones into repeatable market entry and clinical adoption for Dx and MedTech companies.

Evidence & Clinical Utility

Design clinical and economic evidence that demonstrates real-world utility for Dx and MedTech products.

Regulatory & Market Access

Sequence FDA pathways, reimbursement strategy, and payer engagement to unlock sustainable adoption.

Adoption Infrastructure

Build the commercial systems for physician engagement, channel placement, and scalable clinical uptake.

COMMERCIAL READINESS

Clearance Does Not Create Adoption

Regulatory progress advances the product. It does not establish commercial readiness.

Unclear launch sequencing
Evidence not payer-aligned
Channel decisions delayed
Pricing defined too late
Activity without repeatable adoption
Investor pressure increasing

This is where market entry risk begins.

The greatest risk in diagnostics is not scientific failure. It is the failure to reach clinical adoption.

We build the bridge.

THE PATH TO CLINICAL ADOPTION

From Validation to Clinical Adoption

A clear progression from clinical evidence to sustainable commercial adoption.

Scientific Validation

Evidence Strategy

Market Access

HOW WE WORK

Three Phases. One Architecture.

A structured, hands-on approach that connects market-entry planning with commercial execution.

Phase 01: Strategic Audit

Phase 02: Structural Design

Phase 03: Guided Execution

WHO WE SUPPORT

For the Leaders Accountable for Adoption

Diagnostic Innovators

Medical Device Firms

Strategic Investors

NEXT STEP

Is Your Diagnostic Ready for Clinical Adoption?

FDA clearance is only one step toward commercial success. Understanding your clinical evidence, market access, and adoption readiness can help identify potential barriers before they affect your launch.

Take the AdvisoryDx Commercial Readiness Assessment or connect with us to discuss your commercialization strategy.

Start with the 4-minute assessment, or go straight to a 30-minute conversation.

STAY CURRENT

Subscribe to AdvisoryDx Insights

A monthly briefing on diagnostic market trends, competitive intelligence, product pricing, market-entry strategies, and commercial growth.

Recent topics: emerging diagnostic technologies, competitive market dynamics, pricing strategies, and distribution channel development.

Practical insights. No noise. Unsubscribe anytime.

NAVIGATE

RESOURCES

CONTACT

7901 4th St N, STE 300 St. Petersburg, FL 33702